SARS-CoV (902-947)[K2N,I4S,N9Q,A11E,Q16N,S18V,S23N,A25S,V32D,A37N,A39S,V44Q,Q46E]

General Information


DRACP ID  DRACP03992

Peptide Name   SARS-CoV (902-947)[K2N,I4S,N9Q,A11E,Q16N,S18V,S23N,A25S,V32D,A37N,A39S,V44Q,Q46E]

Sequence  QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE

Sequence Length  46

UniProt ID  P59594 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C216H356N66O83

Absent amino acids  CHMPRWY

Common amino acids  Q

Mass  600845

Pl  4.26

Basic residues  3

Acidic residues  5

Hydrophobic residues  11

Net charge  -2

Boman Index  -13570

Hydrophobicity  -119.13

Aliphatic Index  74.13

Half Life 
  Mammalian: 0.8 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  18

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18983873

Title  Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  15210

DRACP is developed by Dr.Zheng's team.